Grade1/2 | Grade3/4 | |
---|---|---|
Oxaliplatin (n = 58, 73.4%) | ||
Neurotoxicity | 86.2% | 5.2% |
Nausea & Vomiting | 27.6% | |
5-Fluorouracil (n = 47, 59.4%) | ||
Neutropenia | 27.6% | 34.1% |
Hand-Foot Syndrome | 44.7% | 2.1% |
Mucositis | 61.7% | 4.2% |
Diarrhoea | 38.2% | 6.4% |
Capecitabine (n = 31, 39.2%) | ||
Hand-Foot Syndrome | 32.3% | 9.7% |
Mucositis | 29.1% | |
Diarrhoea | 22.6% | 9.7% |
Bevacizumab (n = 44, 55.7%) | ||
Hypertension | 15.9% | 11.4% |
Proteinuria | 63.7% | 4.5% |
Cetuximab/Panitumumab (n = 12, 15.2%) | ||
Paronychia | 75% | |
Cutaneous rash | 75% | 25% |